NIH Deploys Picodya’s B-Matrix In Vitro Diagnostics Platform to Detect Future Global Viral Threats
PREMISE Program, Led by NIAID, Ensures U.S. and Global Readiness for Future Pandemics National Institutes of Health (NIH) laboratories have deployed Picodya‘s B-Matrix™ technology, the first hybrid in vitro diagnostics (IVD) solution for multiplexed…
Read More